
Axenya
Corporate health management.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
* | $12.0m | Series A | |
Total Funding | 000k |
Related Content
Axenya is a cutting-edge digital health platform that aims to transform corporate healthcare management in Latin America. The company leverages advanced technology to create a comprehensive ecosystem that connects various stakeholders in the healthcare journey, including employers, employees, and healthcare providers.
At the core of Axenya's offering is a sophisticated software platform that combines data analytics, artificial intelligence, and behavioral science to optimize healthcare delivery and outcomes. For employers, the company provides a powerful Hub RH system that streamlines and automates the management of health plans and providers, offering valuable insights and metrics to drive informed decision-making.
Employees benefit from the Axenya App, a mobile application connected to over 450 health devices, which captures vital health indicators and offers personalized care plans. This app serves as a central hub for health data, providing users with three levels of support and enabling them to take a more proactive approach to their well-being.
By integrating cutting-edge digital health tools and applications, Axenya creates disease-specific care programs that complement traditional treatments. This approach allows for continuous monitoring of patient behavior outside clinical settings, providing healthcare professionals with new insights and the ability to offer real-time support.
Axenya's innovative solutions have demonstrated impressive results, with 90% of users reporting improved well-being and 78% noting better health habits. The company's focus on preventive care and personalized health management has also led to significant cost savings for corporate clients, with an average portfolio readjustment of only 5% over the past two years.